Sanofi’s Wayrilz Gets Out Of The Blocks With First US Approval For ITP

 
• By Alexandra Shimmings
  
expansion
Sanofi is hoping ITP will be the first in a number of indications for Wayrilz • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip